Personal Injury Law

Lawmakers launch Tylenol recall investigation

The Chicago product liability attorneys at Levin & Perconti have blogged frequently about the recent Tylenol and other over-the-counter drug recalls from Johnson & Johnson?s drug manufacturing division. Now, CNN.com is reporting that lawmakers have announced that began an investigation into the recent product recall of Children?s Tylenol, Motrin, Benadryl, and other over-the-counter drugs. The House Committee on Oversight and Government Reform is asking the Food and Drug Administration (FDA) and Johnson & Johnson?s drug manufacturing division to disclose information on the drug recall and tell what prompted the recall. Important to potential injuries to minors and children, the House is also requesting that they disclose the severity of the impact would be to children who may have taken the recalled over-the-counter drugs.

The Illinois product liability attorneys think this a good action ? especially considering that this recent product recall is the third to include Tylenol products this year. Lawmakers are hoping that the investigation will shed light on whether FDA?s inspection procedures are effective. Additionally, the investigation will also determine whether the division neglected to explore consumer complaints about the problem.

Chicago injury attorneys at Levin & Perconti also came across a helpful Chicago link regarding where you can find a location to dispose of pharmaceuticals. With all of the recent recalls of popular products that consumers use, the link will undoubtedly be helpful. The City of Chicago and the Chicago Police Department are partnering to provide a place for the safe and proper disposal of unused or expired prescription and over-the-counter medications.

To read more about the federal investigation into the recent drug recalls.

Click the link to determine where to dispose of recalled products, including expired prescription and over-the-counter medications.

Full post as published by Illinois Injury Lawyer Blog on May 06, 2010 (boomark / email).